Synthesis and pharmacological evaluation of novel 1- and 8-substituted-3-furfuryl xanthines as adenosine receptor antagonists

Bioorg Med Chem. 2009 Sep 15;17(18):6755-60. doi: 10.1016/j.bmc.2009.07.034. Epub 2009 Jul 23.

Abstract

The synthesis of an important set of 3-furfurylxanthine derivatives is described. Binding affinities were determined for rat A(1) and human A(2A), A(2B) and A(3) receptors. Several of the 3-furfuryl-7-methylxanthine derivatives showed moderate-to-high affinity at human A(2B) receptors, the most active compound (10d) having a K(i) of 7.4 nM for hA(2B) receptors, with selectivities over rA(1) and hA(2A) receptors up to 14-fold and 11-fold, respectively. Affinities for hA(3) receptors were very low for all members of the set.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine A1 Receptor Antagonists
  • Adenosine A2 Receptor Antagonists
  • Adenosine A3 Receptor Antagonists
  • Animals
  • Cell Line
  • Humans
  • Protein Binding
  • Purinergic P1 Receptor Antagonists*
  • Rats
  • Receptor, Adenosine A1 / metabolism
  • Receptor, Adenosine A2A / metabolism
  • Receptor, Adenosine A2B / metabolism
  • Receptor, Adenosine A3 / metabolism
  • Receptors, Purinergic P1 / metabolism*
  • Structure-Activity Relationship
  • Xanthines / chemical synthesis
  • Xanthines / chemistry*
  • Xanthines / pharmacology*

Substances

  • Adenosine A1 Receptor Antagonists
  • Adenosine A2 Receptor Antagonists
  • Adenosine A3 Receptor Antagonists
  • Purinergic P1 Receptor Antagonists
  • Receptor, Adenosine A1
  • Receptor, Adenosine A2A
  • Receptor, Adenosine A2B
  • Receptor, Adenosine A3
  • Receptors, Purinergic P1
  • Xanthines